Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Nonpeptide T-20-like HIV entry inhibitors identified by New York Blood Center

July 23, 2003

L-Lysine protease inhibitor with a unique resistance profile

July 23, 2003

Ampligen delays HIV rebound during structured HAART interruption

July 22, 2003

New-generation NNRTI with potential for use in NNRTI-experienced HIV patients

July 22, 2003

Shionogi researchers describe a novel series of HIV integrase inhibitors

July 17, 2003

Boehringer Ingelheim and Medivir sign agreement for MIV-310

July 16, 2003

BMS identifies series of HIV integrase inhibitors

July 10, 2003

Immune Response evaluates second-generation HIV vaccine

July 10, 2003

Emtriva approved by FDA for treatment of HIV

July 7, 2003

Preparations for Italian phase II Remune study

July 3, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...